Well if you are considering it you might have to wait a year or two for clinical trial results and commercial approval. Most likely it will result in a partnership deal with an established player like Edwards.
But from a technical point of view, it ticks an awful lot of boxes. If the trial results bear this out it's probably going to be irresistible to someone.
- Forums
- ASX - By Stock
- AVR
- Anteris Channel 9 Interview 2022
Anteris Channel 9 Interview 2022, page-30
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.78 |
Change
-0.070(0.37%) |
Mkt cap ! $362.3M |
Open | High | Low | Value | Volume |
$19.00 | $19.00 | $18.75 | $79.94K | 4.237K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1428 | $18.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.96 | 402 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 531 | 18.780 |
1 | 379 | 18.750 |
1 | 50 | 18.610 |
1 | 53 | 18.520 |
2 | 51 | 18.510 |
Price($) | Vol. | No. |
---|---|---|
18.980 | 421 | 1 |
19.040 | 497 | 2 |
19.070 | 24 | 1 |
19.080 | 240 | 2 |
19.100 | 108 | 1 |
Last trade - 11.41am 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$18.80 |
  |
Change
-0.070 ( 0.21 %) |
|||
Open | High | Low | Volume | ||
$19.02 | $19.02 | $18.77 | 241 | ||
Last updated 11.41am 28/05/2024 ? |
Featured News
AVR (ASX) Chart |